Fortis Noida’s Dr. Munshi: The Only Doctor from India Contributing to Global Standards for Breast Cancer and Axillary Radiation Therapy
Noida, April : Breast cancer is one of the leading causes of cancer-related deaths among women worldwide, despite treatment strategies continuously evolving to improve patient outcomes. One of the key areas of focus in breast cancer treatment is axillary radiation therapy, which plays a crucial role in managing the disease, particularly in cases where cancer spreads to the lymph nodes. The challenge for oncologists is to find a balance between treating the disease effectively and reducing the side effects, so patients can have a better quality of life.
Recognizing the importance of these advancements, Dr. Anusheel Munshi, Director of Radiation Oncology at Fortis Hospital, Noida, was invited as a distinguished panelist at the renowned St. Gallen International Breast Cancer Conference in Vienna. As the sole Indian oncologist on the St. Gallen Voting Panel, Dr. Munshi played a key role in shaping global guidelines for breast cancer treatment alongside leading experts from around the world.
At the conference, Dr. Munshi gave an informative talk on managing the axilla in breast cancer patients, focusing on proven strategies to improve radiation therapy. He discussed ways to make treatment more effective while minimizing side effects, especially in patients who have already had chemotherapy.
Dr. Munshi also played a key role in the St. Gallen Consensus Voting Panel, a globally recognized forum that sets international standards for breast cancer treatment. His participation underscored the growing influence of Indian oncology expertise in global medical discourse.
Expressing his honor at being part of the esteemed panel, Dr. Munshi stated, “Being the sole invited faculty from India at this prestigious forum is both a privilege and a responsibility. The discussions held at St. Gallen will help shape the future of breast cancer treatment worldwide, ensuring that patients receive the best possible care.”
Dr. Munshi’s contributions at the conference reaffirm his dedication to advancing breast cancer treatment and strengthening India’s position in the global oncology community.